address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,hasPrePostMarketData,firstTradeDateMilliseconds,shortName,longName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,marketState,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,trailingPegRatio
20th KM Hosur Road,Electronic City,Bengaluru,560100,India,91 80 2808 2808,91 80 2852 3423,https://www.biocon.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.","[{'maxAge': 1, 'name': 'Dr. Kiran  Mazumdar-Shaw B.Sc (Hons), B.Sc.', 'age': 71, 'title': 'Founder & Executive Chairperson', 'yearBorn': 1953, 'fiscalYear': 2024, 'totalPay': 38430000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Siddharth  Mittal BCom, CA, CPA', 'age': 46, 'title': 'MD, CEO & Director', 'yearBorn': 1978, 'fiscalYear': 2024, 'totalPay': 57310000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mukesh  Kamath', 'title': 'Chief Financial Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Arun  Gupta', 'title': 'Head of Operations', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Atanu  Roy', 'title': 'Group Chief Information Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Saurabh  Paliwal', 'title': 'Head of Investor Relations', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Seema Shah Ahuja BA, MBA', 'age': 58, 'title': 'Global Head of Communications & Corporate Brand', 'yearBorn': 1966, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Maninder Kapoor Puri', 'age': 51, 'title': 'Head of Human Resources', 'yearBorn': 1973, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul Vazhayil Thomas', 'age': 51, 'title': 'Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business', 'yearBorn': 1973, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Abhijit  Zutshi', 'title': 'Commercial Head of Biocon Global Generics', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",3,2,9,1,4,1748736000,1735603200,[],86400,2,348.6,348.05,344.55,352.9,348.6,348.05,344.55,352.9,0.5,0.14,1751500800,0.0591,1.16,0.219,41.4817,35.418346,3624085,3624085,3295533,6464151,6464151,0.0,0.0,0,0,420938383360,291.0,404.7,2.7581358,334.394,345.56,0.5,0.0014343086,INR,False,616298774528,0.06639,445703389,1198060032,0.62544996,0.18439,1198060032,180.658,1.944835,1743379200,1774915200,1743379200,1.542,10133000192,8.47,9.92,2:1,1560297600,4.038,19.438,0.008388758,0.094471335,0.5,1751587200,EQUITY,351.35,447.0,270.0,377.2,395.0,2.27778,buy,20,45651001344,38.104,31705999360,183619993600,0.708,1.136,152616992768,66.259,127.451,0.01679,0.05395,92441001984,-28161748992,40611999744,1.55,0.128,0.60570997,0.20775,0.15977,INR,BIOCON.NS,en-US,US,Equity,Delayed Quote,True,HIGH,False,1081309500000,BIOCON LIMITED.,Biocon Limited,"[{'header': 'Dividend', 'message': 'BIOCON.NS announced a cash dividend of 0.50 with an ex-date of Jul. 4, 2025', 'meta': {'eventType': 'DIVIDEND', 'dateEpochMs': 1751567400000, 'amount': '0.50'}}]",1750413602,NSI,finmb_8835628,Asia/Kolkata,IST,19800000,in_market,False,0.78886974,351.35,POSTPOST,2.75,344.55 - 352.9,NSE,3295533,60.350006,0.20738834,291.0 - 404.7,-53.350006,-0.13182606,0.8388758,1746701940,1754477940,1754913600,1746761400,1746761400,True,8.47,9.92,6.66902,52.683903,16.955994,0.05070663,5.7900085,0.016755436,15,15,2.3 - Buy,False,
